Company Website

Virtual Booth

Nick Marchand
nmarchand@flexiontherapeutics.com
267-394-0545

Virtual Exhibit Hall Home

Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the discovery, development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Visit flexiontherapeutics.com.

We embrace a philosophy of scientific entrepreneurship which spurs innovation and empowers and inspires our people to discover, develop and commercialize transformative therapies which can make a meaningful difference in the lives of patients.

Flexion was co-founded in 2007 by Michael Clayman, M.D., and Neil Bodick, M.D., Ph.D., who leveraged the extensive drug development expertise they gained over decades at Eli Lilly and Company.

Please visit us at our Virtual Booth